Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""attenuated"" wg kryterium: Temat


Tytuł :
Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.
Autorzy :
Sulyok Z; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Fendel R; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany. .; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany. .
Eder B; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Lorenz FR; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Kc N; Sanaria Inc, Rockville, MD, USA.
Karnahl M; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Lalremruata A; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Nguyen TT; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Held J; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Adjadi FAC; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Klockenbring T; Fraunhofer Institute of Molecular Biology and Applied Ecology IME, Aachen, Germany.
Flügge J; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Woldearegai TG; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Lamsfus Calle C; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Ibáñez J; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Rodi M; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Egger-Adam D; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Kreidenweiss A; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Köhler C; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Esen M; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Sulyok M; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
Manoj A; Sanaria Inc, Rockville, MD, USA.
Richie TL; Sanaria Inc, Rockville, MD, USA.
Sim BKL; Sanaria Inc, Rockville, MD, USA.
Hoffman SL; Sanaria Inc, Rockville, MD, USA.
Mordmüller B; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Kremsner PG; Institute of Tropical Medicine, University and University Hospital of Tübingen, Tübingen, Germany.; German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 May 04; Vol. 12 (1), pp. 2518. Date of Electronic Publication: 2021 May 04.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Malaria Vaccines/*immunology
Malaria, Falciparum/*prevention & control
Plasmodium falciparum/*immunology
Vaccination/*methods
Vaccines, Attenuated/*immunology
Adult ; Antimalarials/therapeutic use ; Cell Line ; Chemoprevention ; Chloroquine/therapeutic use ; Female ; Humans ; Immunoglobulin G/immunology ; Malaria Vaccines/adverse effects ; Malaria, Falciparum/drug therapy ; Malaria, Falciparum/immunology ; Malaria, Falciparum/parasitology ; Male ; Parasitemia/immunology ; Protein Array Analysis ; Sporozoites/immunology ; Vaccination/adverse effects ; Vaccines, Attenuated/adverse effects
Czasopismo naukowe
Tytuł :
Dissecting serotype-specific contributions to live oral cholera vaccine efficacy.
Autorzy :
Sit B; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA 02115.; Department of Microbiology, Harvard Medical School, Boston, MA 02115.
Fakoya B; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA 02115.; Department of Microbiology, Harvard Medical School, Boston, MA 02115.
Zhang T; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA 02115.; Department of Microbiology, Harvard Medical School, Boston, MA 02115.
Billings G; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA 02115.; Department of Microbiology, Harvard Medical School, Boston, MA 02115.
Waldor MK; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA 02115; .; Department of Microbiology, Harvard Medical School, Boston, MA 02115.; Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, MA 02115.; Howard Hughes Medical Institute, Boston, MA 02115.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Feb 16; Vol. 118 (7).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunogenicity, Vaccine*
Serogroup*
Cholera Vaccines/*immunology
Vaccines, Attenuated/*immunology
Vibrio cholerae/*immunology
Administration, Oral ; Animals ; Cholera Vaccines/administration & dosage ; Cholera Vaccines/genetics ; Female ; Mice ; Mice, Inbred C57BL ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/genetics ; Vibrio cholerae/genetics
Czasopismo naukowe
Tytuł :
Live vaccines and immunosuppressive monoclonal antibodies: weighing up the benefit-risk assessment for natalizumab.
Autorzy :
Schwob JM; Division of Tropical and Humanitarian Medicine, Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
Samer CF; Division of Clinical Pharmacology and Toxicology, Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.; Division of Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Swiss Centre for Applied Human Toxicology, Geneva, Switzerland.
Lalive PH; Department of Neurosciences, Division of Neurology, Faculty of Medicine, Geneva University Hospitals, Geneva, Switzerland.; Department of Diagnostic, Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland.
Eperon GA; Division of Tropical and Humanitarian Medicine, Department of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland.
Pokaż więcej
Źródło :
Journal of travel medicine [J Travel Med] 2021 Apr 14; Vol. 28 (3).
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal*/adverse effects
Antibodies, Monoclonal*/therapeutic use
Natalizumab*/adverse effects
Natalizumab*/therapeutic use
Vaccines, Attenuated*/adverse effects
Vaccines, Attenuated*/therapeutic use
Humans ; Immunosuppressive Agents/adverse effects ; Immunosuppressive Agents/therapeutic use ; Risk Assessment
Czasopismo naukowe
Tytuł :
Attenuation Methods for Live Vaccines.
Autorzy :
Hajra D; Department of Microbiology and Cell Biology, Indian Institute of Science, Bengaluru, India.
Datey A; Centre for Biosystems Science and Engineering, Indian Institute of Science, Bengaluru, India.
Chakravortty D; Department of Microbiology and Cell Biology, Indian Institute of Science, Bengaluru, India. .; Centre for Biosystems Science and Engineering, Indian Institute of Science, Bengaluru, India. .
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2183, pp. 331-356.
Typ publikacji :
Journal Article
MeSH Terms :
Vaccines, Attenuated/*immunology
Vaccinology/*methods
Animals ; Bacterial Vaccines ; Cell Line ; Codon Usage ; Female ; Gamma Rays ; Gene Silencing ; Humans ; Immunization ; Immunogenicity, Vaccine ; Influenza A virus ; Mice ; MicroRNAs/genetics ; Models, Animal ; Mutagenesis ; Orthomyxoviridae Infections/immunology ; Orthomyxoviridae Infections/prevention & control ; Protozoan Vaccines/genetics ; Protozoan Vaccines/immunology ; Radiation, Ionizing ; Vaccines, Attenuated/genetics ; Virulence/immunology
Czasopismo naukowe
Tytuł :
Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.
Autorzy :
Gurwith M; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA.
Condit RC; Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL, USA.
Excler JL; International Vaccine Institute, Seoul, Republic of Korea.
Robertson JS; Independent Adviser, United Kingdom.
Kim D; Janssen Pharmaceuticals, Titusville, NJ, USA.
Fast PE; International AIDS Vaccine Initiative, New York, NY, USA; Stanford School of Medicine, Paolo Alto, CA, USA.
Drew S; Independent Adviser, USA.
Wood D; Independent Adviser, United Kingdom.
Klug B; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
Whelan M; Project Leader, CEPI, UK.
Mallett Moore T; Sanofi Pasteur, Swiftwater, PA, USA.
Khuri-Bulos N; University of Jordan, Amman, Jordan.
Smith ER; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA. Electronic address: .
Chen RT; Brighton Collaboration, A Program of the Task Force for Global Health, Decatur, GA, USA.
Kochhar S; Global Healthcare Consulting, New Delhi, India; University of Washington, Seattle, WA, USA.
Pokaż więcej
Corporate Authors :
Brighton Collaboration Viral Vector Vaccines Safety Working Group V3SWG
Źródło :
Vaccine [Vaccine] 2020 Nov 17; Vol. 38 (49), pp. 7702-7707. Date of Electronic Publication: 2020 Oct 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Drug Evaluation, Preclinical/*standards
Vaccines, Attenuated/*adverse effects
Viral Vaccines/*adverse effects
COVID-19 Vaccines/adverse effects ; COVID-19 Vaccines/pharmacology ; Drug Evaluation, Preclinical/methods ; Humans ; Risk Assessment ; Societies, Scientific ; Vaccines, Attenuated/pharmacology ; Viral Vaccines/pharmacology
Czasopismo naukowe
Tytuł :
Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.
Autorzy :
Jahnmatz M; Public Health Agency of Sweden, Solna, Sweden.
Richert L; University of Bordeaux, National Institute for Health and Medical Research (Inserm), Bordeaux Population Health Research Center, Bordeaux, France; University Hospital Centre CHU, Bordeaux, France; EUCLID/F-CRIN Clinical Trials Platform, Bordeaux, France; Inria SISTM team, F-33405, Talence, France.
Al-Tawil N; Karolinska Trial Alliance, Karolinska University Hospital, Stockholm, Sweden.
Storsaeter J; Public Health Agency of Sweden, Solna, Sweden.
Colin C; University of Bordeaux, National Institute for Health and Medical Research (Inserm), Bordeaux Population Health Research Center, Bordeaux, France; University Hospital Centre CHU, Bordeaux, France; EUCLID/F-CRIN Clinical Trials Platform, Bordeaux, France.
Bauduin C; University of Bordeaux, National Institute for Health and Medical Research (Inserm), Bordeaux Population Health Research Center, Bordeaux, France; University Hospital Centre CHU, Bordeaux, France; EUCLID/F-CRIN Clinical Trials Platform, Bordeaux, France.
Thalen M; ILiAD Biotechnologies, New York, NY, USA.
Solovay K; ILiAD Biotechnologies, New York, NY, USA.
Rubin K; ILiAD Biotechnologies, New York, NY, USA.
Mielcarek N; University of Lille, National Centre for Scientific Research (CNRS), National Institute for Health and Medical Research (Inserm), University Hospital Centre CHU Lille, Lille, France; Center for Infection and Immunity of Lille, Institut Pasteur de Lille, Lille, France.
Thorstensson R; Public Health Agency of Sweden, Solna, Sweden.
Locht C; University of Lille, National Centre for Scientific Research (CNRS), National Institute for Health and Medical Research (Inserm), University Hospital Centre CHU Lille, Lille, France; Center for Infection and Immunity of Lille, Institut Pasteur de Lille, Lille, France. Electronic address: .
Pokaż więcej
Corporate Authors :
BPZE1 study team
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2020 Nov; Vol. 20 (11), pp. 1290-1301. Date of Electronic Publication: 2020 Jul 17.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Administration, Intranasal*
Immunogenicity, Vaccine*
Vaccination*
Pertussis Vaccine/*immunology
Vaccines, Attenuated/*immunology
Adult ; Antigens, Bacterial/immunology ; Bordetella pertussis/immunology ; Double-Blind Method ; Female ; Follow-Up Studies ; Healthy Volunteers ; Humans ; Immunoglobulin A/blood ; Immunoglobulin A/immunology ; Immunoglobulin G/blood ; Immunoglobulin G/immunology ; Male ; Pertussis Vaccine/administration & dosage ; Pertussis Vaccine/adverse effects ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/adverse effects ; Whooping Cough/microbiology ; Whooping Cough/prevention & control ; Young Adult
Czasopismo naukowe
Tytuł :
Characterization of four types of MLV-derived porcine reproductive and respiratory syndrome viruses isolated in unvaccinated pigs from 2016 to 2020.
Autorzy :
Chen N; College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, PR China; Joint International Research Laboratory of Agriculture and Agri-Product Safety, Yangzhou, Jiangsu 225009, PR China; Comparative Medicine Research Institute, Yangzhou University, Yangzhou, Jiangsu 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, PR China. Electronic address: .
Li X; College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, PR China.
Xiao Y; College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, PR China.
Li S; College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, PR China.
Zhu J; College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, PR China; Joint International Research Laboratory of Agriculture and Agri-Product Safety, Yangzhou, Jiangsu 225009, PR China; Comparative Medicine Research Institute, Yangzhou University, Yangzhou, Jiangsu 225009, PR China; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou 225009, PR China. Electronic address: .
Pokaż więcej
Źródło :
Research in veterinary science [Res Vet Sci] 2021 Jan; Vol. 134, pp. 102-111. Date of Electronic Publication: 2020 Dec 22.
Typ publikacji :
Journal Article
MeSH Terms :
Vaccines, Attenuated*/genetics
Viral Vaccines*/administration & dosage
Viral Vaccines*/genetics
Viral Vaccines*/immunology
Porcine Reproductive and Respiratory Syndrome/*virology
Porcine respiratory and reproductive syndrome virus/*isolation & purification
Swine Diseases/*virology
Animals ; China ; Genomics ; Phylogeny ; Porcine Reproductive and Respiratory Syndrome/prevention & control ; Porcine respiratory and reproductive syndrome virus/genetics ; Porcine respiratory and reproductive syndrome virus/immunology ; Porcine respiratory and reproductive syndrome virus/pathogenicity ; Swine ; Swine Diseases/prevention & control ; Virulence
Czasopismo naukowe
Tytuł :
Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine.
Autorzy :
Litt J; Discipline of General Practice College of Medicine and Public Health, Flinders University , Adelaide, Australia.
Booy R; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The University of Sydney , Sydney, Australia.
Bourke D; Medical Department, Seqirus (Australia) Pty Ltd , Parkville, Australia.
Dwyer DE; NSW Health Pathology - Institute for Clinical Pathology and Medical Research, Westmead Hospital and the University of Sydney , Sydney, Australia.
Leeb A; Illawarra Medical Centre , Ballajura, Australia.
McCloud P; McCloud Consulting Group , Belrose, Australia.
Stein AN; Helath Economics, Seqirus (Australia) Pty Ltd , Parkville, Australia.
Woodward M; Centre for Virus Research, Aged Care Services, Austin Health, University of Melbourne , Melbourne, Australia.
Cunningham AL; Faculty of Medicine and Health, The Westmead Institute for Medical Research , Westmead, Australia.; The University of Sydney , Sydney, Australia.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2020 Dec 01; Vol. 16 (12), pp. 3081-3089. Date of Electronic Publication: 2020 May 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Herpes Zoster*/epidemiology
Herpes Zoster*/prevention & control
Herpes Zoster Vaccine*/therapeutic use
Neuralgia, Postherpetic*/epidemiology
Neuralgia, Postherpetic*/prevention & control
Vaccines, Attenuated*
Adult ; Aged ; Australia/epidemiology ; Herpesvirus 3, Human/immunology ; Humans ; Vaccination
Czasopismo naukowe
Tytuł :
A porcine macrophage cell line that supports high levels of replication of OURT88/3, an attenuated strain of African swine fever virus.
Autorzy :
Portugal R; The Pirbright Institute, Surrey, UK.
Goatley LC; The Pirbright Institute, Surrey, UK.
Husmann R; Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Zuckermann FA; Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.; Aptimmune Biologics, Inc., St Louis, MO, USA.
Dixon LK; The Pirbright Institute, Surrey, UK.
Pokaż więcej
Źródło :
Emerging microbes & infections [Emerg Microbes Infect] 2020 Dec; Vol. 9 (1), pp. 1245-1253.
Typ publikacji :
Journal Article
MeSH Terms :
African Swine Fever Virus/*physiology
Cell Culture Techniques/*methods
Macrophages/*cytology
Vaccines, Attenuated/*pharmacology
African Swine Fever/virology ; African Swine Fever Virus/immunology ; African Swine Fever Virus/isolation & purification ; Animals ; Bone Marrow Cells/virology ; Cell Line ; Cell Proliferation ; Macrophages/virology ; Serial Passage ; Swine ; Vaccines, Attenuated/immunology ; Virus Replication
Czasopismo naukowe
Tytuł :
A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool.
Autorzy :
Todorov G; Emotional Brain Institute, Nathan Kline Institute, Orangeburg, NY 10962, USA.
Uversky VN; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.; USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
Pokaż więcej
Źródło :
Biomolecules [Biomolecules] 2020 Oct 14; Vol. 10 (10). Date of Electronic Publication: 2020 Oct 14.
Typ publikacji :
Editorial
MeSH Terms :
Coronavirus Infections/*immunology
Pneumonia, Viral/*immunology
Vaccines, Attenuated/*immunology
Viral Vaccines/*immunology
COVID-19 ; COVID-19 Vaccines ; Coronavirus Infections/prevention & control ; Humans ; Pandemics/prevention & control ; Pneumonia, Viral/prevention & control ; Vaccines, Attenuated/adverse effects ; Viral Vaccines/adverse effects
Opinia redakcyjna
Tytuł :
Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005.
Autorzy :
Durbin AP; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, United States. Electronic address: .
Pokaż więcej
Źródło :
Current opinion in virology [Curr Opin Virol] 2020 Aug; Vol. 43, pp. 79-87. Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :
Historical Article; Journal Article; Review
MeSH Terms :
Drug Development*/history
Dengue/*prevention & control
Dengue Vaccines/*immunology
Dengue Virus/*immunology
Vaccines, Attenuated/*immunology
Dengue/history ; Dengue/immunology ; Dengue/virology ; Dengue Vaccines/administration & dosage ; Dengue Vaccines/genetics ; Dengue Vaccines/history ; Dengue Virus/genetics ; History, 20th Century ; History, 21st Century ; Humans ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/genetics ; Vaccines, Attenuated/history ; Vaccines, Combined/administration & dosage ; Vaccines, Combined/genetics ; Vaccines, Combined/history ; Vaccines, Combined/immunology
Czasopismo naukowe
Tytuł :
Development of Attenuated Total Reflectance Mid-Infrared (ATR-MIR) and Near-Infrared (NIR) Spectroscopy for the Determination of Resistant Starch Content in Wheat Grains.
Autorzy :
Wang, Rong (AUTHOR)
Wei, Xia (AUTHOR)
Wang, Hongpan (AUTHOR)
Zhao, Linshu (AUTHOR)
Zeng, Cengli (AUTHOR)
Wang, Bingrui (AUTHOR)
Zhang, Wenying (AUTHOR)
Liu, Luxiang (AUTHOR)
Xu, Yanhao (AUTHOR)
Pokaż więcej
Źródło :
Journal of Analytical Methods in Chemistry. 7/15/2021, p1-9. 9p.
Czasopismo naukowe
Tytuł :
[Vaccination of immunocompromised patients: when and when not to vaccinate].
Autorzy :
Goorhuis A; Amsterdam Universitair Medische Centra, Centrum voor Tropische Geneeskunde & Reizigersgeneeskunde, Amsterdam.; Contact: Abraham Goorhuis ().
Garcia-Garrido HM; Amsterdam Universitair Medische Centra, Centrum voor Tropische Geneeskunde & Reizigersgeneeskunde, Amsterdam.
Vollaard AM; RIVM, Landelijke Coördinatie Infectieziektenbestrijding, Bilthoven.
Pokaż więcej
Transliterated Title :
Vaccinatie van immuungecompromitteerde patiënten.
Źródło :
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2020 Sep 03; Vol. 164. Date of Electronic Publication: 2020 Sep 03.
Typ publikacji :
Journal Article
MeSH Terms :
Immunocompromised Host*
Travel*
Vaccines, Attenuated*/adverse effects
Female ; Humans ; Measles-Mumps-Rubella Vaccine/adverse effects ; Middle Aged ; Yellow Fever Vaccine/adverse effects ; Young Adult
Czasopismo naukowe
Tytuł :
The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines.
Autorzy :
Mok DZL; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore.
Chan KR; Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore 169857, Singapore.
Pokaż więcej
Źródło :
Viruses [Viruses] 2020 May 08; Vol. 12 (5). Date of Electronic Publication: 2020 May 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Antibodies, Viral/*immunology
Vaccines, Attenuated/*immunology
Viral Vaccines/*immunology
Virus Diseases/*immunology
Viruses/*immunology
Animals ; Humans ; Immunogenicity, Vaccine ; Vaccines, Attenuated/administration & dosage ; Vaccines, Attenuated/genetics ; Viral Vaccines/administration & dosage ; Viral Vaccines/genetics ; Virus Diseases/genetics ; Virus Diseases/virology ; Viruses/genetics
Czasopismo naukowe
Tytuł :
Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
Autorzy :
Wang Y; Codagenix Inc., Farmingdale, NY 11735.
Yang C; Codagenix Inc., Farmingdale, NY 11735.
Song Y; Codagenix Inc., Farmingdale, NY 11735.
Coleman JR; Codagenix Inc., Farmingdale, NY 11735.
Stawowczyk M; Codagenix Inc., Farmingdale, NY 11735.
Tafrova J; Codagenix Inc., Farmingdale, NY 11735.
Tasker S; Codagenix Inc., Farmingdale, NY 11735.
Boltz D; Division of Microbiology and Molecular Biology, Illinois Institute of Technology (IIT) Research Institute, Chicago, IL 60616.
Baker R; Division of Microbiology and Molecular Biology, Illinois Institute of Technology (IIT) Research Institute, Chicago, IL 60616.
Garcia L; Division of Microbiology and Molecular Biology, Illinois Institute of Technology (IIT) Research Institute, Chicago, IL 60616.
Seale O; Division of Microbiology and Molecular Biology, Illinois Institute of Technology (IIT) Research Institute, Chicago, IL 60616.
Kushnir A; Codagenix Inc., Farmingdale, NY 11735.
Wimmer E; Department of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794 .
Mueller S; Codagenix Inc., Farmingdale, NY 11735; .
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Jul 20; Vol. 118 (29).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
COVID-19/*immunology
COVID-19/*prevention & control
COVID-19 Vaccines/*immunology
COVID-19 Vaccines/*pharmacology
SARS-CoV-2/*immunology
Animals ; Antibodies, Viral/immunology ; COVID-19/epidemiology ; Chlorocebus aethiops ; Female ; Humans ; Male ; Mesocricetus ; Pandemics ; Spike Glycoprotein, Coronavirus/genetics ; Spike Glycoprotein, Coronavirus/immunology ; Vaccination ; Vaccines, Attenuated/immunology ; Vero Cells
Czasopismo naukowe
Tytuł :
Vaccination with Rift Valley fever virus live attenuated vaccine strain Smithburn caused meningoencephalitis in alpacas.
Autorzy :
Anthony T; Provincial Veterinary Laboratory, Department of Agriculture, Western Cape Government, Capetown, South Africa.
van Schalkwyk A; South Africa Agricultural Research Council-Onderstepoort Veterinary Institute, Onderstepoort, South Africa.
Romito M; South Africa Agricultural Research Council-Onderstepoort Veterinary Institute, Onderstepoort, South Africa.
Odendaal L; Department of Paraclinical Sciences, University of Pretoria, Onderstepoort, South Africa.
Clift SJ; Department of Paraclinical Sciences, University of Pretoria, Onderstepoort, South Africa.
Davis AS; Department of Paraclinical Sciences, University of Pretoria, Onderstepoort, South Africa.; Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA.
Pokaż więcej
Źródło :
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc [J Vet Diagn Invest] 2021 Jul; Vol. 33 (4), pp. 777-781. Date of Electronic Publication: 2021 May 27.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Camelids, New World*
Meningoencephalitis/*veterinary
Rift Valley fever virus/*immunology
Vaccination/*veterinary
Vaccines, Attenuated/*administration & dosage
Viral Vaccines/*adverse effects
Animals ; Female ; Male ; Meningoencephalitis/diagnosis ; Meningoencephalitis/virology ; South Africa ; Vaccination/adverse effects
Czasopismo naukowe
Tytuł :
Safety enhancement of a genetically modified live rabies vaccine strain by introducing an attenuating Leu residue at position 333 in the glycoprotein.
Autorzy :
Ito N; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan; The United Graduate School of Veterinary Sciences, Gifu University, Gifu, Japan; Joint Graduate School of Veterinary Sciences, Gifu University, Japan. Electronic address: .
Okamoto T; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.
Sasaki M; Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Miyamoto S; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.
Takahashi T; The United Graduate School of Veterinary Sciences, Gifu University, Gifu, Japan.
Izumi F; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.
Inukai M; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.
Jarusombuti S; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan; Graduate School of Bioagricultural Science, Nagoya University, Japan.
Okada K; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.
Nakagawa K; The United Graduate School of Veterinary Sciences, Gifu University, Gifu, Japan.
Fujii Y; Joint Graduate School of Veterinary Sciences, Gifu University, Japan.
Nishiyama S; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan; Joint Graduate School of Veterinary Sciences, Gifu University, Japan.
Masatani T; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan; Joint Graduate School of Veterinary Sciences, Gifu University, Japan.
Sawa H; Division of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.
Sugiyama M; Laboratory of Zoonotic Diseases, Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan.
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2021 Jun 23; Vol. 39 (28), pp. 3777-3784. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Rabies*/prevention & control
Rabies Vaccines*/genetics
Rabies virus*
Animals ; Glycoproteins/genetics ; Mice ; Vaccines, Attenuated/genetics
Czasopismo naukowe
Tytuł :
Plague vaccines: new developments in an ongoing search.
Autorzy :
Rosenzweig JA; Department of Biology, Texas Southern University, Houston, TX, 77004, USA. .
Hendrix EK; Departmnet of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.
Chopra AK; Departmnet of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA. .
Pokaż więcej
Źródło :
Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2021 Jun; Vol. 105 (12), pp. 4931-4941. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
COVID-19*
Plague*
Plague Vaccine*
Yersinia pestis*
Animals ; Antibodies, Bacterial ; China ; Humans ; SARS-CoV-2 ; Vaccines, Attenuated
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies